Abnormalities in Iron Metabolism in Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  1989-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S0317167100028869PMID 2731085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The genetics of haemochromatosis.

  1988cited by this paper
• HLA alleles, hemochromatosis allele, and serum ferritin in hemodialysis patients.

  1988cited by this paper
• Usefulness of erythrocyte ferritin analysis in hereditary hemochromatosis.

  1987cited by this paper
• Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

  1987cited by this paper
• MRI of brain iron.

  1986cited by this paper
• Iron deposits and multiple sclerosis.

  1984cited by this paper
• Genetic and phenotypic expression of hemochromatosis in Canadians.

  1983cited by this paper
• Iron deposits surrounding multiple sclerosis plaques.

  1982cited by this paper
• Mineral Composition of Brains of Normal and Multiple Sclerosis Victims

  1980cited by this paper
• Genetics of hemochromatosis.

  1979cited by this paper
• Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

  1977cited by this paper
• Serum ferritin and the iron status of Canadians.

  1976cited by this paper
• International abstracts of pediatric surgerySerotyping for homotransplantation : R. Patel, M. R. Mickey, and P. I. Terasaki. New Eng. J. Med. 279:501–506 (September 5) 1968

  1969cited by this paper
• SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TEST

  1968cited by this paper

• Iron deposition in multiple sclerosis: overall load or distribution alteration?

  2022cites this paper
• IgG3 + B cells are associated with the development of multiple sclerosis

  2020influential citation
• Trace Elements in Serum Samples of Patients with Multiple Sclerosis

  2017cites this paper
• Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid.

  2017cites this paper
• Physiology of iron metabolism Systemic iron regulation − the hepcidin − ferroportin

  2017cites this paper
• Iron metabolism as a therapeutic target for drug development and delivery

  2017cites this paper
• Targeting iron metabolism in drug discovery and delivery

  2017cites this paper
• Iron metabolism in neuromyelitis optica patients.

  2014cites this paper
• Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study

  2012cites this paper
• The effect of smoking on the symptoms and progression of multiple sclerosis: a review

  2010cites this paper
• Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.

  2008cites this paper
• Association of SLC11A1 promoter polymorphisms with the incidence of autoimmune and inflammatory diseases: a meta-analysis.

  2008cites this paper
• Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.

  2008cites this paper
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

  2008cites this paper
• High resolution inductively coupled plasma mass spectrometry: Some applications in biomedicine

  2008cites this paper
• THE ROLE OF DOPAMINE OXIDATION IN DOPAMINE-INDUCED TOXICITY, INITIATION OF ENDOPLASMIC RETICULUM STRESS, AND POTENTIATION OF ROTENONE-INDUCED TOXICITY IN DIFFERENTIATED PC12 CELLS

  2007cites this paper
• Biomarkers for Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Possible mechanisms mediating neurodegeneration

  2007cites this paper
• Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis

  2006cites this paper
• Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis

  2006cites this paper
• Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients

  2005cites this paper
• Mutations in the hemochromatosis gene (HFE) and multiple sclerosis.

  2005cites this paper
• Oxidation-induced ferritin turnover in microglial cells: role of proteasome.

  2005cites this paper
• Neurodegenerative markers : insights into multiple sclerosis

  2005cites this paper
• Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis

  2004cites this paper
• Role of Iron Metabolism in Multiple Sclerosis

  2003cites this paper
• Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis

  2003cites this paper
• Oxidative stress in Parkinson's disease

  2003cites this paper
• Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis.

  2003cites this paper
• A multi-disciplinary approach towards elucidating the genetics of multiple sclerosis

  2003cites this paper
• Apoferritin Attenuates Experimental Allergic Encephalomyelitis in SJL Mice

  2002cites this paper
• Dopamine in the CNS II

  2002cites this paper
• Molecular and Cellular Events Regulating Dopamine Neuron Survival

  2002cites this paper
• Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects.

  2001cites this paper
• Sequestration of iron by Lewy bodies in Parkinson’s disease

  2000cites this paper
• Analysis of hereditary haemochromatosis and clinical correlations in the elderly

  2000cites this paper
• Untersuchung der Plasmaoxidierbarkeit und des Antioxidantienstatus im Blutplasma von Patienten mit Morbus Parkinson: ein Beitrag zur Frage des oxidativen Streß in der Pathogenese des Morbus Parkinson

  2000cites this paper
• The Role of Iron in Parkinson Disease and 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Toxicity

  1999cites this paper
• Understanding cell death in parkinson's disease

  1998cites this paper
• Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders

  1996cites this paper
• Oxidative stress and the pathogenesis of Parkinson's disease

  1996cites this paper
• Oxidative stress: Free radical production in neural degeneration

  1994cites this paper
• Oxidative stress: free radical production in neural degeneration.

  1994cites this paper
• What is it that l‐deprenyl (selegiline) might do? *

  1994cites this paper
• Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease

  1993cites this paper
• Presymptomatic detection of Parkinson's disease.

  1993cites this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

  1992cites this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.

  1992cites this paper
• Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

  1991cites this paper